Publication Details

Pubmed11888936
Title: Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), a novel Hsp90-client tyrosine kinase: down-regulation of NPM-ALK expression and tyrosine phosphorylation in ALK(+) CD30(+) lymphoma cells by the Hsp90 antagonist 17-allylamino,17-demethoxygeldanamycin.
Year: 2002
First Author: Bonvini
Experimental setup: affinity chromatography technology (Biogrid)
in vitro (Hprd)
in vivo (Hprd)
Throughput: Low Throughput (Biogrid)

Interactions

5 interactions